JNJ vs PFE: Johnson & Johnson vs Pfizer
Both JNJ (Johnson & Johnson) and PFE (Pfizer) operate in the Pharma sector. They are often compared as direct peers.
$JNJ · Johnson & Johnson
Why We Increased The Position In Johnson & Johnson
Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market
$PFE · Pfizer
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Pfizer Inks Up to $10.5 Billion Deal With China’s Innovent - Bloomberg.com
Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom - Reuters
Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing
UBS maintains Pfizer stock rating ahead of cancer drug trial results
BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results
Frequently Asked Questions
What is the main difference between JNJ and PFE?
JNJ is Johnson & Johnson (sector: Pharma). PFE is Pfizer (sector: Pharma). They differ in business model, geography, and product mix — catalysts that move one may not move the other.
Are JNJ and PFE direct competitors?
They are in the same sector and often direct competitors. Check the latest news feed on both tickers for current competitive dynamics.
How do I track JNJ and PFE news in real time?
Catalayer aggregates news from 30+ sources in real time for both JNJ and PFE. Follow /stocks/JNJ and /stocks/PFE for live feeds, or create a custom monitor for either.
Which stock performs better historically?
Past performance varies by timeframe and regime. Catalayer provides real-time news and AI analysis but does not provide investment advice or performance-ranked recommendations.